Grade My Investments
Home › Free Stock Grades › QTRX

Quanterix Corporation (QTRX) Stock Grade

QTRX · Healthcare

C
Grade updated: September 29, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$165.8M
P/E Ratio
—
Revenue Growth (YoY)
+2.4%
Net Margin
-77.3%
Return on Equity
—
Dividend Yield
None

About Quanterix Corporation's fundamentals

Quanterix Corporation is a small-cap medical device company with a market capitalization of $165.8 million that reported modest revenue growth of 2.4% year-over-year. However, the company is currently unprofitable, with a net margin of -77.3% and a reported net loss in its latest annual statement, indicating that expenses significantly exceed revenues. The company does not pay a dividend and cannot be evaluated using standard profitability metrics like P/E ratio or return on equity due to its loss-making status.

Track QTRX free — no credit card required. Live grade + monthly AI report →